greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2023

Sanofi (SNY) annual results, year to 31 December 2023: revenue EUR 37,817 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2023 it reported revenue from the sale of goods of EUR 37,817 million ($40.9 billion at the year's average rate), up 0.4% on the year before. Its profit attributable to shareholders was EUR 5,400 million, down 35.5%, and diluted earnings per share EUR 4.30.

Revenue
EUR 37,817 million
+0.4% on the year
FY2016FY2023
Operating margin
18.4%
27.0% a year earlier
FY2016FY2023
Net income
EUR 5,400 million
-35.5% on the year
FY2016FY2023
Diluted EPS
EUR 4.30
-35.4% on the year
FY2016FY2023

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2022 †Dec 2023 †
Revenue from the sale of goods37,65137,817
Cost of sales11,88212,628
Gross profit28,67928,990
Research and development6,5016,507
Selling, general and administrative8,7398,933
Operating profit10,1626,960
Finance costs4301,293
Income tax1,9091,017
Profit for the year8,4845,436
Profit attributable to shareholders8,3715,400
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2022 †Dec 2023 †
Diluted EPS6.664.30
Basic EPS6.694.31
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2022 †Dec 2023 †
Cash from operations10,52610,258
Cash from investing-2,075-6,200
Cash from financing-5,821-8,052
Buybacks497593
Dividends paid4,1684,454
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2022 †Dec 2023 †
Funded by
Equity attributable to shareholders74,78474,040
Non-controlling interests368313
Borrowings, as filed19,21816,531
Lease liabilities2,1812,030
Other liabilities30,17133,550
Total equity and liabilities126,722126,464
Owned
Property, plant and equipment9,86910,160
Goodwill49,89249,404
Other intangible assets21,64024,319
Cash and cash equivalents12,7368,710
Inventories8,9609,666
Other assets23,62524,205
Total assets126,722126,464
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2022 †Dec 2023 †
Return on year-end equity11.2%7.3%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2023, filed 17 February 2026: the filing. The figures are in euros as filed.